Banque Transatlantique Sa Editas Medicine, Inc. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 468 shares of EDIT stock, worth $725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
468Holding current value
$725% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
48.4MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$12.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.47MShares$11.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$4.12 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$4.03 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$3.01 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $107M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...